Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.

While the last decade has brought considerable progress for patients with DMD, substantial unmet need remains. Several ...

Iowa dentist is facing licensing sanctions related to a January 2024 dental procedure that resulted in the death of a 50-year ...

Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...

Dr Monica Bijlani was ordered to pay £87,663 damages by the High Court after negligently drilling into the wrong tooth ...

The gene therapy delandistrogene moxeparvovec-rokl showed clinically meaningful benefits and disease stabilization at 2 years ...

Prophylactic cardiac treatment may prolong survival in Duchenne muscular dystrophy (DMD), but only one-quarter of individuals ...

Arizona dentist Dr. Walter Villanueva must hire chaperones after his ex-assistant, accused of assaulting and photographing ...

Virtual reality has been a standout technology in the medical industry since the turn of the decade. From its use as a ...

Pharmaceuticals announced positive top-line results from its Phase 2 FIGHT DMD trial. The study evaluated ifetroban, a novel ...

Following a dental assistant being accused of sexual assault in 2024, Kidiatric Dental is required to have a chaperone on ...